Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Cabozantinib Shows Encouraging Activity in Advanced Renal Cell Carcinoma - Drug Discovery Development |
 |
 |
|
Drug Discovery & Development Exelixis Inc. reported preliminary data from pre-treated patients with metastatic refractory renal cell carcinoma (RCC) participating in an ongoing Phase 1b trial of cabozantinib, a potent, dual inhibitor of MET and VEGFR2 that provides coordinated ... Cabozantinib Shows Encouraging Activity in Heavily Pretreated Patients With |
